NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Lung Cancer Therapeutics market worldwide is projected to grow by US$24 Billion, driven by a compounded growth of 12.9%. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed and sized in this study, displays the potential to grow at over 14%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$28.1 Billion by the year 2025, Non-Small-Cell Lung Cancer (NSCLC) will bring in healthy gains adding significant momentum to global growth.
Read the full report: https://www.reportlinker.com/p05817749/?utm_source=PRN
- Representing the developed world, the United States will maintain a 11.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$948.9 Million to the region's size and clout in the next 5 to 6 years. Over US$771 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Non-Small-Cell Lung Cancer (NSCLC) will reach a market size of US$1.4 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.7% over the next couple of years and add approximately US$5.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.
Read the full report: https://www.reportlinker.com/p05817749/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Lung Cancer Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Lung Cancer Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Lung Cancer Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Lung Cancer Therapeutics Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market
by Region/Country in US$ Million: 2018 to 2025
Table 5: Non-Small-Cell Lung Cancer (NSCLC) (Type) Historic
Market Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Small-Cell Lung Cancer (SCLC) (Type) Potential Growth
Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Small-Cell Lung Cancer (SCLC) (Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Small-Cell Lung Cancer (SCLC) (Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Lung Cancer Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 10: United States Lung Cancer Therapeutics Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 11: Lung Cancer Therapeutics Market in the United States
by Type: A Historic Review in US$ Million for 2009-2017
Table 12: United States Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
CANADA
Table 13: Canadian Lung Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018 to 2025
Table 14: Canadian Lung Cancer Therapeutics Historic Market
Review by Type in US$ Million: 2009-2017
Table 15: Lung Cancer Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
JAPAN
Table 16: Japanese Market for Lung Cancer Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 17: Lung Cancer Therapeutics Market in Japan: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 18: Japanese Lung Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
CHINA
Table 19: Chinese Lung Cancer Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 20: Lung Cancer Therapeutics Historic Market Analysis in
China in US$ Million by Type: 2009-2017
Table 21: Chinese Lung Cancer Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Lung Cancer Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 22: European Lung Cancer Therapeutics Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 23: Lung Cancer Therapeutics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 24: European Lung Cancer Therapeutics Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 25: European Lung Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 26: Lung Cancer Therapeutics Market in Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 27: European Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
FRANCE
Table 28: Lung Cancer Therapeutics Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 29: French Lung Cancer Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 30: French Lung Cancer Therapeutics Market Share Analysis
by Type: 2009 VS 2019 VS 2025
GERMANY
Table 31: Lung Cancer Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 32: German Lung Cancer Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 33: German Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
ITALY
Table 34: Italian Lung Cancer Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 35: Lung Cancer Therapeutics Historic Market Analysis in
Italy in US$ Million by Type: 2009-2017
Table 36: Italian Lung Cancer Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 37: United Kingdom Market for Lung Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 38: Lung Cancer Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Type for the
Period 2009-2017
Table 39: United Kingdom Lung Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
SPAIN
Table 40: Spanish Lung Cancer Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 41: Spanish Lung Cancer Therapeutics Historic Market
Review by Type in US$ Million: 2009-2017
Table 42: Lung Cancer Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
RUSSIA
Table 43: Russian Lung Cancer Therapeutics Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 44: Lung Cancer Therapeutics Market in Russia by Type: A
Historic Review in US$ Million for 2009-2017
Table 45: Russian Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 46: Rest of Europe Lung Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Type: 2018-2025
Table 47: Lung Cancer Therapeutics Market in Rest of Europe in
US$ Million by Type: A Historic Review for the Period 2009-2017
Table 48: Rest of Europe Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 49: Asia-Pacific Lung Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 50: Lung Cancer Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 51: Asia-Pacific Lung Cancer Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 52: Lung Cancer Therapeutics Market in Asia-Pacific by
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 53: Asia-Pacific Lung Cancer Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 54: Asia-Pacific Lung Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 55: Lung Cancer Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 56: Australian Lung Cancer Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 57: Australian Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
INDIA
Table 58: Indian Lung Cancer Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 59: Indian Lung Cancer Therapeutics Historic Market
Review by Type in US$ Million: 2009-2017
Table 60: Lung Cancer Therapeutics Market in India: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
SOUTH KOREA
Table 61: Lung Cancer Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 62: South Korean Lung Cancer Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 63: Lung Cancer Therapeutics Market Share Distribution in
South Korea by Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Market for Lung Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 65: Lung Cancer Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Type
for the Period 2009-2017
Table 66: Rest of Asia-Pacific Lung Cancer Therapeutics Market
Share Analysis by Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 67: Latin American Lung Cancer Therapeutics Market Trends
by Region/Country in US$ Million: 2018-2025
Table 68: Lung Cancer Therapeutics Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 69: Latin American Lung Cancer Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 70: Latin American Lung Cancer Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 71: Lung Cancer Therapeutics Historic Market Analysis in
Latin America in US$ Million by Type: 2009-2017
Table 72: Latin American Lung Cancer Therapeutics Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 73: Argentinean Lung Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 74: Lung Cancer Therapeutics Market in Argentina in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 75: Argentinean Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
BRAZIL
Table 76: Lung Cancer Therapeutics Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 77: Brazilian Lung Cancer Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 78: Brazilian Lung Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
MEXICO
Table 79: Lung Cancer Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 80: Mexican Lung Cancer Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 81: Mexican Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 82: Rest of Latin America Lung Cancer Therapeutics Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 83: Lung Cancer Therapeutics Market in Rest of Latin
America by Type: A Historic Review in US$ Million for 2009-2017
Table 84: Rest of Latin America Lung Cancer Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 85: The Middle East Lung Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 86: Lung Cancer Therapeutics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 87: The Middle East Lung Cancer Therapeutics Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 88: The Middle East Lung Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Table 89: The Middle East Lung Cancer Therapeutics Historic
Market by Type in US$ Million: 2009-2017
Table 90: Lung Cancer Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2009, 2019,
and 2025
IRAN
Table 91: Iranian Market for Lung Cancer Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 92: Lung Cancer Therapeutics Market in Iran: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 93: Iranian Lung Cancer Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
ISRAEL
Table 94: Israeli Lung Cancer Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 95: Lung Cancer Therapeutics Market in Israel in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 96: Israeli Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 97: Saudi Arabian Lung Cancer Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 98: Lung Cancer Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Type: 2009-2017
Table 99: Saudi Arabian Lung Cancer Therapeutics Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 100: Lung Cancer Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 101: United Arab Emirates Lung Cancer Therapeutics
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 102: Lung Cancer Therapeutics Market Share Distribution
in United Arab Emirates by Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 103: Lung Cancer Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Type for the Period 2018-2025
Table 104: Rest of Middle East Lung Cancer Therapeutics
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 105: Rest of Middle East Lung Cancer Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
AFRICA
Table 106: African Lung Cancer Therapeutics Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 107: Lung Cancer Therapeutics Market in Africa by Type: A
Historic Review in US$ Million for 2009-2017
Table 108: African Lung Cancer Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
IV. COMPETITION
BRISTOL-MYERS SQUIBB COMPANY
F. HOFFMANN-LA ROCHE AG
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER, INC
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817749/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article